Skip to Main content Skip to Navigation
Journal articles

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

Moisés Calderon 1 Pascal Demoly 2, 3 Thomas Casale 4 Cezmi Akdis 5 Claus Bachert 6 Michael Bewick 7 Maria Beatrice Bilò 8 Barbara Bohle 9 Sergio Bonini 10, 11 A Bush 1 Davide Caimmi 2, 3 Giorgio Walter Canonica 12 Victoria Cardona 13 Anca Mirela Chiriac 2, 3 Linda Cox 14 Adnan Custovic 1 Frédéric de Blay 15 Philippe Devillier 16 Alain Didier 17 Gabriele Di Lorenzo 18, 19, 20 George Du Toit 19 Stephen Durham 1 Peter Eng 21 Alessandro Fiocchi 22 A. T. Fox 19 Roy Gerth van Wijk 23 R. M. Gomez 24 Tari Haathela 25 Susanne Halken 26 Peter Hellings 27 Lars Jacobsen 28 Jocelyne Just 2, 29 Luciana Tanno 2, 30, 31 J. Kleine-Tebbe 32 Ludger Klimek 33 Edward Knol 34 Piotr Kuna 35 Désirée Larenas-Linnemann 36, 37 Allan Linneberg 38, 39, 40 M. Matricardi 41 Hans-Joergen Malling 42 Ralph Moesges 43 Joaquim Mullol 44 Antonella Muraro 45 Nikos Papadopoulos Giovanni Passalacqua 12 Elideanna Pastorello 46 Olivier Pfaar 47, 48, 49 David Price 50, 51, 52 Pablo Rodriguez del Rio 53 R. Ruëff 54 Boleslaw Samolinski 55 Glenis Scadding 56, 57 Gabriela Senti 58 Mohamed Shamji 1, 59 Aziz Sheikh 60 Juan Carlos Sisul 61 Dirceu Sole 62 Gunter Sturm 63, 64 Ana Tabar 65 Ronald van Ree 66 Maria Teresa Ventura 67 Carmen Vidal 68 Eva Maria Varga 63 Margitta Worm 41 Torsten Zuberbier 41 Jean Bousquet 69, 70, *
* Corresponding author
Abstract : Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
Document type :
Journal articles
Complete list of metadatas

Cited literature [129 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01401204
Contributor : Bmc Bmc <>
Submitted on : Wednesday, November 23, 2016 - 8:03:09 AM
Last modification on : Friday, October 23, 2020 - 4:52:29 PM
Long-term archiving on: : Tuesday, March 21, 2017 - 10:20:53 AM

File

13601_2016_Article_131.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Moisés Calderon, Pascal Demoly, Thomas Casale, Cezmi Akdis, Claus Bachert, et al.. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clinical and Translational Allergy, BioMed Central, 2016, 6 (1), pp.41. ⟨10.1186/s13601-016-0131-x⟩. ⟨inserm-01401204⟩

Share

Metrics

Record views

261

Files downloads

263